Dr Stefan MildeUniversity positionResearch Associate DepartmentsDepartment of Medical Genetics InstitutesAlzheimer’s Research UK Cambridge Drug Discovery Institute Research ThemeInterestsCell-based assay development and screening for drug discovery in dementia. Research Focus
EquipmentCell culture Enzyme assays Fluorescence microscopy High Content Imaging Microscopy CollaboratorsNo collaborators listed Associated News ItemsPublications2013Milde S, Fox AN, Freeman MR, Coleman MP (2013), “Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo.” Sci Rep 3:2567 Details Milde S, Gilley J, Coleman MP (2013), “Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.” Bioarchitecture 3(5):133-140 Details Milde S, Gilley J, Coleman MP (2013), “Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2.” PLoS Biol 11(4):e1001539 Details 2012Osterloh JM, Yang J, Rooney TM, Fox AN, Adalbert R, Powell EH, Sheehan AE, Avery MA, Hackett R, Logan MA, MacDonald JM, Ziegenfuss JS, Milde S, Hou YJ, Nathan C, Ding A, Brown RH Jr, Conforti L, Coleman M, Tessier-Lavigne M, Züchner S, Freeman MR (2012), “dSarm/Sarm1 is required for activation of an injury-induced axon death pathway.” Science 337(6093):481-4 Details 2010Wood NI, Carta V, Milde S, Skillings EA, McAllister CJ, Ang YL, Duguid A, Wijesuriya N, Afzal SM, Fernandes JX, Leong TW, Morton AJ (2010), “Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington's disease.” PLoS One 5(2):e9077 Details |